ANDA 91242, held by Impax Labs Inc. Anastrozole.
As of Nov 16, 2026, ANDA 91242 (Anastrozole), held by Impax Labs Inc, was first approved by FDA on May 31, 2012, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 31, 2012 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Anastrozole1MG ยท tablet;oral | Anastrozole | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters